Zhengnan Huang

发表

TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT

Yilin Yan, B. Shen, Xiangqian Cao, 2021, OncoTargets and therapy.

Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer

Yilin Yan, Tengjiao Wang, B. Shen, 2022, Journal of translational medicine.

Downregulation of TET1 Promotes Bladder Cancer Cell Proliferation and Invasion by Reducing DNA Hydroxymethylation of AJAP1

B. Shen, Yi Yan, Jun Yan, 2020, Frontiers in Oncology.

Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer

Yilin Yan, S. Xia, B. Shen, 2022, Frontiers in Molecular Biosciences.

Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer

Yilin Yan, Mingyue Tan, B. Shen, 2020, Aging.

CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling

Yilin Yan, Mingyue Tan, Ruimin Huang, 2021, Cell Death & Disease.

Establishment of an optimized orthotopic bladder cancer model in mice

Yilin Yan, Mingyue Tan, B. Shen, 2022, BMC Urology.

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer

Yilin Yan, B. Shen, Xiangqian Cao, 2021, Frontiers in Cell and Developmental Biology.

A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer

Yilin Yan, B. Shen, Chenkai Yang, 2023, BMC Urology.

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer

Yilin Yan, Mingyue Tan, B. Shen, 2023, Frontiers in Genetics.

PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7

Yilin Yan, Mingyue Tan, Ruimin Huang, 2021, Frontiers in Cell and Developmental Biology.

Mechanisms of Xiaozheng decoction for anti-bladder cancer effects via affecting the GSK3β/β-catenin signaling pathways: a network pharmacology-directed experimental investigation

Yilin Yan, B. Shen, Chenkai Yang, 2023, Chinese Medicine.

Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling

Yifeng Jing, Ruimin Huang, B. Han, 2020, BMC Complementary Medicine and Therapies.

FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer

Yilin Yan, Xiangqian Cao, Chengdang Xu, 2024, International journal of medical sciences.

IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer

Yilin Yan, Chenkai Yang, Xiangqian Cao, 2024, Cancer cell international.